연구동향 분석

Original Article : Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension

( Jae Hyun Kim ) ( Jung Min Kim ) ( Youn Zoo Cho ) ( Ji Hoon Na ) ( Hyun Sik Kim ) ( Hyoun A Kim ) ( Hye Won Kang ) ( Soon Koo Baik ) ( Sang Ok Kwon ) ( Seung Hwan Cha ) ( Young Ju Kim ) Moon-Young Kim 2014년

논문상세정보
인용/피인용
' Original Article : Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • angiotensinreceptorblocker
  • cirrhosis
  • hepaticvenouspressuregradient
  • non-selectivebetablocker
  • portal hypertension
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,713 0

0.0%

' Original Article : Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension' 의 참고문헌

  • Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
    Yokohama S Hepatology 40 : 1222 ~ 1225 - [2004]
  • The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data
    홍원기 Clinical and Molecular Hepatology 19 (4) : 370 ~ 375 [2013]
  • The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide
    Rockey D. Hepatology 25 : 2 ~ 5 - [1997]
  • Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis
    Feu F1 Lancet 346 : 1056 ~ 1059 - [1995]
  • Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response
    Baik SK Radiology 240 : 574 ~ 580 - [2006]
  • Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis
    González-Abraldes J Gastroenterology 121 : 382 ~ 388 - [2001]
  • Portal pressure response to losartan compared with propranolol in patients with cirrhosis
    De BK Am J Gastroenterol 98 : 1371 ~ 1376 - [2003]
  • Pharmacological reduction of portal pressure and longterm risk of first variceal bleeding in patients with cirrhosis
    Turnes J Am J Gastroenterol 101 : 506 ~ 512 - [2006]
  • Multicenter Italian Group. End-ofthe-century reappraisal of the 6-week outcome of upper gastrointestinal bleeding in cirrhosis. A prospective study
    D’Amico G J Hepatol 30 : 86 ~ [1999]
  • Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
    Friedman SL. J Biol Chem 275 : 2247 ~ 2250 - [2000]
  • Invasive and non-invasive diagnosis of cirrhosis and portal hypertension
    Kim MY World J Gastroenterol 20 : 4300 ~ 4315 - [2014]
  • Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension
    Kim MY J Hepatol 55 : 1004 ~ 1009 - [2011]
  • Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis
    Kim MY Eur J Gastroenterol Hepatol 21 : 1241 ~ 1246 - [2009]
  • Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis
    Kim MY Hepatology 56 : 1053 ~ 1062 - [2012]
  • Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage
    Groszmann RJ Gastroenterology 99 : 1401 ~ 1407 - [1990]
  • Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension
    Schepke M Gastroenterology 121 : 389 ~ 395 - [2001]
  • Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis
    Schneider AW Hepatology 29 : 334 ~ 339 - [1999]
  • Effect of Propranolol on Portal Pressure and Systemic Hemodynamics in Patients with Liver Cirrhosis and Portal Hypertension: A Prospective Study
    Ki Tae Suk Gut and Liver 1 (2) : 159 ~ 164 - [2007]
  • Differential response of normal and cirrhotic liver to vasoactive agents. A study in the isolated perfused rat liver
    Ballet F J Pharmacol Exp Ther 244 : 283 ~ 289 - [1988]
  • Diagnosis of portal hypertension: how and when, Portal Hypertension III
    D’Amico G Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies : 36 ~ 64 [2001]
  • Complications of cirrhosis. I. Portal hypertension
    Bosch J J Hepatol 32 : 141 ~ 156 - [2000]
  • Comparison of portal vein velocity and the hepatic venous pressure gradient in assessing the acute portal hemodynamic response to propranolol in patients with cirrhosis
    Schepke M Am J Gastroenterol 95 : 2905 ~ 2909 - [2000]
  • Clinical features and outcomes of gastric variceal bleeding: retrospective Korean multicenter data
    김문영 Clinical and Molecular Hepatology 19 (1) : 36 ~ 44 [2013]
  • Candesartan cilexetil. A review of its use in essential hypertension
    McClellan KJ Drugs 56 : 847 ~ 869 - [1998]
  • Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor
    Ojima M Eur J Pharmacol 319 : 137 ~ 146 - [1997]
  • Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis
    Groszmann RJ N Engl J Med 353 : 2254 ~ 2261 - [2005]
  • Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - a randomized open-label controlled study
    Kim MY Liver Int 32 : 977 ~ 987 - [2012]
  • Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model
    Kim MY J Gastroenterol 43 : 889 ~ 896 - [2008]
  • Angiotensin II receptor antagonists
    Burnier M Lancet 355 : 637 ~ 645 - [2000]
  • Angiotensin II induces contraction and proliferation of human hepatic stellate cells
    Bataller R Gastroenterology 118 : 1149 ~ 1156 - [2000]
  • Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis:a randomized comparison
    Baik SK Am J Gastroenterol 100 : 631 ~ 635 - [2005]